Antidepressant Fluvoxamine in Reducing COVID-19 Hospitalization
DOI:
https://doi.org/10.36283/PJMD11-2/015Abstract
Dear Editor,
In this era of the 21st century, when a global pandemic has taken over the lives of millions, causing severe hospitalization and even death, the need for treatment has become an ongoing challenge despite the relative progress made by vaccination.
Downloads
Published
2024-05-16
Issue
Section
Letter to the Editor
License
Copyright (c) 2024 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
Metrics
How to Cite
1.
Shakil S, Akhtar SE, Ali A. Antidepressant Fluvoxamine in Reducing COVID-19 Hospitalization. PJMD [Internet]. 2024 May 16 [cited 2026 Jun. 24];11(2):95-6. Available from: https://ojs.zu.edu.pk/pjmd/article/view/1639
